Pages that link to "Q54965181"

The following pages link to Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy (Q54965181):

Displaying 43 items.

• Hormone replacement therapy for women previously treated for endometrial cancer (Q24234201) (← links)
• Hormone replacement therapy for women previously treated for endometrial cancer (Q26471218) (← links)
• Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy (Q31784650) (← links)
• Long-term postmenopausal hormone therapy and endometrial cancer (Q33650188) (← links)
• Hormone replacement therapy and the endometrium (Q34263283) (← links)
• Menopausal hormone therapy and risk of endometrial cancer (Q34345110) (← links)
• Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium (Q34996134) (← links)
• Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer (Q35510465) (← links)
• Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats (Q36066982) (← links)
• Sex Steroids and Cancer in Older Women (Q36215680) (← links)
• Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model (Q36901959) (← links)
• Estrogen and progesterone together expand murine endometrial epithelial progenitor cells (Q37174277) (← links)
• A risk-benefit assessment of estrogen therapy in postmenopausal women (Q37974171) (← links)
• Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy? (Q38520052) (← links)
• Hormone replacement therapy in the aged. A state of the art review (Q39467095) (← links)
• Bleeding patterns during continuous combined estrogen-progestogen therapy (Q39509797) (← links)
• The Effects of Conjugated Estrogens on Gonadotropins (Q39572420) (← links)
• Climacteric symptoms and hormonal replacement therapy: a risk or an opportunity? (Q40719192) (← links)
• Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women (Q40760251) (← links)
• The practicalities of hormone replacement therapy (Q40877130) (← links)
• Progesterone therapy results in partial reversibility of uterine abnormalities of the adult anovulatory rat. (Q42874560) (← links)
• Effect of tibolone administration on heart rate variability and free fatty acid levels in postmenopausal women (Q44203348) (← links)
• Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group (Q44602608) (← links)
• Effects of norethisterone acetate addition to estradiol in long term HRT. (Q48713124) (← links)
• Transdermal hormonal replacement therapy with transdermal progestin every second month (Q50595832) (← links)
• Metabolic effect of two hormonal preparations in postmenopausal women (Q50936280) (← links)
• Bioequivalence assessment of three different estradiol formulations in postmenopausal women in an open, randomized, single-dose, 3-way cross-over study. (Q53928518) (← links)
• Cardiovascular risk factors during sequentially combined 17 beta oestradiol and dydrogesterone (Femoston); results from a one-year study in postmenopausal women. (Q53972828) (← links)
• Hormone replacement therapy for women previously treated for endometrial cancer (Q57689276) (← links)
• Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer (Q68307960) (← links)
• The histochemistry of isocitric and oestradiol-17 beta dehydrogenases in the endometrium of postmenopausal women treated with oestrogens and progestogens (Q68726460) (← links)
• [The role of progestins] (Q69557214) (← links)
• Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women (Q70900767) (← links)
• Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium (Q71012624) (← links)
• Postmenopausal osteoporosis (Q71642102) (← links)
• Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group (Q72410741) (← links)
• Oestrogen/progestagen for postmenopausal osteoporosis (Q72477959) (← links)
• Stimulating natural fibrinolysis (Q72477976) (← links)
• Endometrial hyperplasia in women on cyclic or continuous estrogen regimens (Q72923110) (← links)
• Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy (Q72925214) (← links)
• A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles (Q73388160) (← links)
• Morphologic and morphometric aspects of the endometrium of postmenopausal women before and after cyclic oestrogen replacement treatment (Q73556571) (← links)
• Comparison of two HRT regimens with bimonthly and monthly progestin administration in postmenopause (Q77396375) (← links)